Cereblon (CRBN) was originally identified as a protein involved in human intellectual disability and has recently been recognized as a negative regulator of adenosine monophosphate-activated protein kinase (AMPK) in vivo and in vitro . Here we present results showing that CRBN can effectively regulate new protein synthesis via the mammalian target rapamycin (mTOR) signaling pathway, […]
Weiterlesen